Market Research Logo

Global Protein Engineering Market - Segmented By Product Type, Technology, End-user, and Geography - Growth, Trends, and Forecast (2018 - 2023)

Global Protein Engineering Market - Segmented By Product Type, Technology, End-user, and Geography - Growth, Trends, and Forecast (2018 - 2023)

The Protein Engineering Market is expected to witness a CAGR of 15.8% during the forecast period. The demand for protein engineering in developing countries is coupled with the preference of protein therapy over the gene therapy and expiry of top biologics drugs in the near future.

Increase in the Adoption of Protein Drugs Over Non-Protein Drugs

Many of the protein or peptide based drugs are being developed, and their quantity and frequency of usage has increased dramatically, for example, drugs like tissue plasminogen activator, human growth hormone, interleukin-2, and erythropoietin. Protein drugs have a high adoption rate in terms of size, molecular weight, formulation, delivery route, and therapeutic response. The peptide and protein drugs are also used in the treatment of the neurodegenerative diseases. The potential benefits of the protein drugs are immense, and the continued investment in developing therapeutic proteins or peptides is expected to be profitable in the long-run, which is ultimately driving the protein engineering market.
Other factors include, increased demand for alternatives to chemical processes, increasing prevalence of protein deficient diseases, and the increase in government funding.

Lack of Experts to Strategize the Process

Despite many investments in the protein manufacturing sector, there is shortage of skilled labor, which is hindering the protein engineering market in most of the developed and under-developed countries. Few of the recent advancement in protein engineering technologies require skilled technicians. This trend applies to the techniques, such as genetic engineering, high-throughput screening, X-ray crystallography etc. This needs high qualified researchers coupled with essential training for the technicians in order to perform the procedures. Thus, shortage of highly-skilled personnel in many developing countries is ultimately restraining the market of protein engineering.
Other factors restraining the growth market are high costs and high-maintenance tools & instruments, used in protein engineering.

North America Dominates the Market

North America region is dominating the market which is being followed by Europe and APAC, regions due to the rising prevalence of lifestyle associated diseases and increasing adoption of protein based drugs in the regions. The Governments of the US, Canada, and Brazil have been highly supportive of advancements in protein engineering, creating a favorable regulatory environment for companies in the North American market. The Asia-Pacific region is also anticipated to grow with a decent CAGR in the upcoming years.

Key Developments in the Market

March 2017: Agilent Technologies launched a research-grade triple quadrupole LC/MS system. This product was launched for expanding research capabilities, to provide greater accuracy and sensitivity in various applications, such as environmental, clinical research, peptide quantitation, and forensic toxicology

November 2017: Thermo Fisher Scientific has launched Invitrogen TrueCut Cas9 Protein v2; that is the next generation CRISPR-Cas9 protein, designed to deliver maximum editing efficiency in a broad range of cells, including standard, immune, primary, and stem cells

Major Players: THERMO FISHER SCIENTIFIC, ELI LILLY AND COMPANY, SIGMA-ALDRICH CORPORATION, PERKINELMER, INC., BRUKER CORPORATION, AGILENT TECHNOLOGIES, BIO-RAD LABORATORIES INC., WATERS CORPORATION, AMGEN, AND NOVO NORDISK, amongst others.

Reasons to Purchase this Report

Current and future global Protein Engineering Market outlook in the developed and emerging markets
Various perspectives of the market, with the help of Porter’s five forces analysis
The segment expected to dominate the market
The region expected to witness the fastest growth rate during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
3 months analyst support, along with the Market Estimate sheet (in Excel)


Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.


1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Force Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Prevalence of Protein Deficient Diseases
6.1.2 Increased Demand for Alternatives to Chemical Processes
6.1.3 Increase in Adoption of Protein Drugs over Non-Protein Drugs
6.1.4 Rising Government Funding for Protein Engineering
6.2 Market Restraints
6.2.1 Lack of Experts to Strategize the Process
6.2.2 High Costs
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Product Type
7.1.1 Modified Proteins
7.1.2 Modified Enzymes
7.1.3 Insulin
7.1.4 Monoclonal Antibodies
7.1.5 Blood Factors
7.1.6 Tissue Plasminogen Activator
7.1.7 Fusion Proteins
7.1.8 Others
7.2 By Technology
7.2.1 Irrational Protein Design
7.2.2 Rational Protein Design
7.3 By End-user
7.3.1 Pharma & Biotech Companies
7.3.2 Academic Institutions
7.3.3 Contract Research Organizations (CRO)
7.4 By Geography
7.4.1 North America
7.4.1.1 United States
7.4.1.2 Canada
7.4.1.3 Mexico
7.4.2 Europe
7.4.2.1 France
7.4.2.2 Germany
7.4.2.3 United Kingdom
7.4.2.4 Italy
7.4.2.5 Spain
7.4.2.6 Rest of Europe
7.4.3 Asia-Pacific
7.4.3.1 China
7.4.3.2 Japan
7.4.3.3 India
7.4.3.4 Australia & New Zealand
7.4.3.5 South Korea
7.4.3.6 Rest of Asia-Pacific
7.4.4 Middle East & Africa
7.4.4.1 GCC
7.4.4.2 South Africa
7.4.4.3 Rest of the Middle East & Africa
7.4.5 South America
7.4.5.1 Brazil
7.4.5.2 Argentina
7.4.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers and Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Thermo Fisher Scientific
9.2 Eli Lilly and Company
9.3 Sigma-Aldrich Corporation
9.4 PerkinElmer, Inc.
9.5 Bruker Corporation
9.6 Agilent Technologies
9.7 Bio-Rad Laboratories, Inc.
9.8 Waters Corporation
9.9 Amgen
9.10 Novo Nordisk
9.11 List Not Exhaustive
10. Future of the market

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report